Russia registers new locally developed smallpox drug Neokh-14

Russia has officially registered Neokh-14, a domestically developed antiviral drug for smallpox and related infections, according to a report by Ajel English. The drug, developed at the State Research Center of Virology and Biotechnology Vector, has been proven effective in treating infections caused by the smallpox virus, as well as monkeypox and cowpox.

Anna Popova, head of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor), announced the registration, highlighting the drug's potential in combating the resurgence of smallpox concerns following recent monkeypox outbreaks in various countries.

Brief written by urgent.news from Ajel English's own syndicated text. Machine-written — may contain errors; check the original before relying on it.